Does pain relief during delivery decrease the risk of postnatal depression?
Pauliina Hiltunen, Tytti Raudaskoski, Hanna Ebeling, Irma Moilanen, Pauliina Hiltunen, Tytti Raudaskoski, Hanna Ebeling, Irma Moilanen
Abstract
Background: To test the hypothesis that sufficient pain relief during delivery decreases the risk of postnatal depression.
Methods: As part of a prospective follow-up study of the risk factors for postnatal depression and its impact on the mother-infant interaction and child development, 185 parturients filled in the Edinburgh Postnatal Depression Scale (EPDS), first during the first postpartum week and again (n = 162) 4 months later. The incidence and the risk of high EPDS scores was calculated according to the mode of delivery and the mode of pain relief during vaginal delivery, also after adjusting for the length of labor.
Results: Mothers who received epidural/paracervical blockade during their delivery spent less time in the delivery room than mothers in the nitrous oxide/acupuncture group (p = 0.033) or mothers with no pain relief (p = 0.026) and had shorter length of labor than mothers without pain relief (p = 0.04). The adjusted risk of depressive scores at the first postnatal week was decreased in the epidural/paracervical group when compared with no analgesia group (OR: 0.25, 95% CI: 0.09-0.72). This difference was not shown at 4 months postpartum. Elective or emergency cesarean section did not increase the risk of high EPDS scores at the first week or at 4 months postpartum.
Conclusion: The mode of pain relief during vaginal delivery seems to be associated with the incidence of postpartum depression, especially immediately after delivery.
Source: PubMed
Aankomende klinische onderzoeken
-
Nicholas ButowskiSiren BiotechnologyNog niet aan het wervenGlioom | Hersenen neoplasma | Terugkerende hooggradige gliomenVerenigde Staten
-
State University of New York at BuffaloNog niet aan het wervenBetrokkenheid van de patiëntVerenigde Staten
-
Poitiers University HospitalNog niet aan het werven
-
Assistance Publique - Hôpitaux de ParisNog niet aan het wervenSikkelcelziekte | Vaso-occlusieve crisis
-
University of California, IrvineWervingHersenkanker | Kanker van het CZS | Kanker van het zenuwstelsel | Hersenkanker UitgezaaidVerenigde Staten
-
Qualia Life SciencesWerving
-
Guangdong Raynovent Biotech Co., LtdNog niet aan het wervenFundamentele wetenschap
-
The Hong Kong Polytechnic UniversityWu Jieh Yee Charitable FoundationWervingVolwassenen | Digitale assistentie voor slechtzienden | Visuele beperkingenHongkong
-
Shanghai General Hospital, Shanghai Jiao Tong University...Nog niet aan het wervenDuctaal adenocarcinoom van de alvleesklier (PDAC)
-
Sun Yat-sen UniversityNog niet aan het wervenStoppen met roken | AI-agent | Early-Stage Cancer
-
Affiliated Hospital of Nantong UniversityNog niet aan het werven
-
AIMEDBIOBoehringer IngelheimNog niet aan het wervenVaste tumorenFrankrijk, Japan, Zuid -Korea, Verenigde Staten, Australië